Pierre Ranger1,2,3, Andréa Senay1,3, Geneviève Rochette Gratton3, Marc Lacelle2, Josée Delisle4,5. 1. Orthopaedic Research Center, Hôpital du Sacré-Coeur de Montréal, 5400, boulevard Gouin Ouest, Montreal, QC, H4J 1C5, Canada. 2. Hôpital Jean-Talon, 1385 rue Jean-Talon est, Montreal, H2E 1S6, Canada. 3. Université de Montréal, 2900 bl. Edouard-Montpetit, Montreal, H3T 1J4, Canada. 4. Orthopaedic Research Center, Hôpital du Sacré-Coeur de Montréal, 5400, boulevard Gouin Ouest, Montreal, QC, H4J 1C5, Canada. josee.delisle@outlook.com. 5. Hôpital Jean-Talon, 1385 rue Jean-Talon est, Montreal, H2E 1S6, Canada. josee.delisle@outlook.com.
Abstract
PURPOSE: The purpose of this study was to describe the longitudinal outcomes of acute repair and augmentation for the reconstruction of dislocated knees, using LARS synthetic ligaments. METHODS: Patients with a knee dislocation surgically treated using LARS synthetic ligament augmentation, with a minimum follow-up of 24 months, were enrolled between 1996 and 2014. Range of motion, Lachman, pivot shift, posterior drawer, step off sign, valgus, varus, KT-1000 arthrometer, Telos technique, IKDC, Lysholm, Tegner, and Meyers scores were obtained every 2 years up to 10 years. RESULTS: Median age was 32.1 years (IQR 23.2-43.3) at time of surgery. Median time from trauma to surgery was 9 days and mean follow-up time was 6.6 years. Median questionnaire scores were: Lysholm 79.5 (IQR 65.0-89.0), Tegner 4.0 (IQR 3.7-6.0), Meyers 3.0 (IQR 3.0-4.0), and mean IKDC was 63.8 (SD 18.9). Median flexion and extension of the injured knee was 124° (IQR 115-129.5) and 0° (IQR - 5 to 0), respectively. Median KT-1000 differential was 0.7 mm (IQR 0.1-3.1) for ACL and 0.9 mm (IQR 0.2-1.4) for PCL. Mean differential for Telos was 2.5 mm (SD 5.8) for ACL, 4 mm (IQR 2-6.3) for PCL 30°, and 8.2 mm (SD 4.4) for PCL 90° (consistent with PCL laxity). More than 90% of patients had good anterior articular stability and > 60% of patients had good posterior articular stability. CONCLUSIONS: Acute repair and augmentation of knee dislocations with LARS synthetic ligaments resulted in satisfactory outcomes for the ACL and collateral structures. Telos stress radiography showed PCL laxity in more than half of cases despite low laxity results with KT-1000. The perception of patients about knee function was sustained in time. LEVEL OF EVIDENCE: IV.
PURPOSE: The purpose of this study was to describe the longitudinal outcomes of acute repair and augmentation for the reconstruction of dislocated knees, using LARS synthetic ligaments. METHODS:Patients with a knee dislocation surgically treated using LARS synthetic ligament augmentation, with a minimum follow-up of 24 months, were enrolled between 1996 and 2014. Range of motion, Lachman, pivot shift, posterior drawer, step off sign, valgus, varus, KT-1000 arthrometer, Telos technique, IKDC, Lysholm, Tegner, and Meyers scores were obtained every 2 years up to 10 years. RESULTS: Median age was 32.1 years (IQR 23.2-43.3) at time of surgery. Median time from trauma to surgery was 9 days and mean follow-up time was 6.6 years. Median questionnaire scores were: Lysholm 79.5 (IQR 65.0-89.0), Tegner 4.0 (IQR 3.7-6.0), Meyers 3.0 (IQR 3.0-4.0), and mean IKDC was 63.8 (SD 18.9). Median flexion and extension of the injured knee was 124° (IQR 115-129.5) and 0° (IQR - 5 to 0), respectively. Median KT-1000 differential was 0.7 mm (IQR 0.1-3.1) for ACL and 0.9 mm (IQR 0.2-1.4) for PCL. Mean differential for Telos was 2.5 mm (SD 5.8) for ACL, 4 mm (IQR 2-6.3) for PCL 30°, and 8.2 mm (SD 4.4) for PCL 90° (consistent with PCL laxity). More than 90% of patients had good anterior articular stability and > 60% of patients had good posterior articular stability. CONCLUSIONS: Acute repair and augmentation of knee dislocations with LARS synthetic ligaments resulted in satisfactory outcomes for the ACL and collateral structures. Telos stress radiography showed PCL laxity in more than half of cases despite low laxity results with KT-1000. The perception of patients about knee function was sustained in time. LEVEL OF EVIDENCE: IV.
Authors: Luke Pugh; Randy Mascarenhas; Shalinder Arneja; Patrick Y K Chin; Jordan M Leith Journal: Am J Sports Med Date: 2008-10-21 Impact factor: 6.202
Authors: Jorge Chahla; Gilbert Moatshe; Mark E Cinque; Grant J Dornan; Justin J Mitchell; Taylor J Ridley; Robert F LaPrade Journal: Arthroscopy Date: 2017-08-31 Impact factor: 4.772
Authors: Ryan S Marder; Husain Poonawala; Jorge I Pincay; Frank Nguyen; Patrick F Cleary; Christine S Persaud; Qais Naziri; Bashir A Zikria Journal: Orthop J Sports Med Date: 2021-10-13